VTAMA (Tapinarof) Cream, 1%
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for VTAMA (Tapinarof) Cream, 1%, covering 2024-07-08 to 2024-08-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region [Phase 4]